MILFORD, Pa., June 16, 2014 /PRNewswire/ -- Fortune Oil
& Gas, Inc. (OTCPink: FOGC), today announced that the company's
wholly owned subsidiary, Manzo Pharmaceuticals has begun a series
of laboratory testing for its patented probiotic formula,
Lacto-Freedom™. Lacto-Freedom™ is designed to stop the symptoms of
lactose intolerance for up to several months after taking it for
just a short time. The company started a six month long study with
different dosages of the probiotic to find the optimum amount
needed to achieve the desired effect. The safety of the
product will also be confirmed over the course of this study and
will prepare the product for human clinical trials. A stability
test may also be performed to determine the best way to store the
product and which dosage form is best (liquid, capsule, freeze
dried powder, or pre-mixed in food) this study will bring Manzo
Pharmaceuticals one-step closer to making this unique treatment
available to the people who need it.
The Lacto-Freedom™ testing started on June 9th, and is being implemented by
Celprogen®, Inc., a California
based research facility specializing in drug studies and clinical
trials such as this. Celprogen® has been conducting in-vitro and
in-vivo biomedical research for over ten years. As a result, they
are the perfect partners to implement these studies.
The company's CEO, Kenneth Manzo,
has been working on a Lacto-Freedom™ Probiotic for over 10 years,
and has high hopes for what he believes will completely change the
lives of people who suffer with this condition. Lactose intolerance
is the inability to digest lactose, a sugar found in milk and milk
products. Currently, patients with lactose intolerance are limited
to avoiding lactose-containing foods or taking lactase supplements
before each meal. Both options are difficult, time-consuming,
embarrassing, and a nuisance. A person may not even be aware that
their meal contains lactose, causing uncomfortable and embarrassing
symptoms. This solution is expected to make those problems a thing
of the past, and with one-in-four people suffering from lactose
intolerance, there is a strong need for a treatment that works well
and works all the time.
Mr. Manzo is extremely confident that this solution will be the
first of many groundbreaking remedies, solutions, and cures to be
developed, and brought to market by the company. There is no doubt
that Manzo Pharmaceuticals is positioning itself to be the most
exciting new pharmaceuticals company in the industry today.
About Fortune Oil & Gas, Inc.
Fortune Oil & Gas, Inc. owns and operates Manzo
Pharmaceuticals, a specialty pharmaceutical company engaged in the
research, development, and testing of patented and non-patented
solutions and remedies. Most notably is Lacto-Freedom™, a patented
solution for lactose Intolerance, and a natural remedy for colic in
babies. For more information follow the company on twitter at
@manzopharma, and visit www.manzopharma.com.
About Celprogen®, Inc.
Celprogen®, Inc. is a biotechnology company developing stem cell
research and therapeutic products for regenerative medicine in
cardiology, oncology, diabetes & neurology. All of Cellprogen's
biological products including stem cells, cancer stem cells, IPC's
& media including ECM's are manufactured and produced in
the United States. Cellprogen®
provides novel molecular diagnostics and therapeutic products
development solutions for biotechnology, pharmaceutical, Invitro
diagnostics and academic partnership for drug discovery. For more
information visit: http://www.celprogen.com
DISCLAIMER:
This Press Release may contain certain
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. The Company has tried,
whenever possible, to identify these forward-looking statements
using words such as "anticipates," "believes," "estimates,"
"expects," "plans," "intends," "potential" and similar expressions.
These statements reflect the Company's current beliefs and are
based upon information currently available to it. Accordingly, such
forward-looking statements involve known and unknown risks,
uncertainties and other factors which could cause the Company's
actual results, performance or achievements to differ materially
from those expressed in or implied by such statements. The Company
undertakes no obligation to update or advise in the event of any
change, addition or alteration to the information catered in this
Press Release including such forward-looking statements.
SOURCE Fortune Oil & Gas, Inc.